Tempus AI (TEM) Reports Q2 Loss, Beats Revenue Estimates

Company Performance - Tempus AI reported a quarterly loss of $0.22 per share, slightly better than the Zacks Consensus Estimate of a loss of $0.23, and an improvement from a loss of $0.63 per share a year ago, representing an earnings surprise of +4.35% [1] - The company posted revenues of $314.64 million for the quarter ended June 2025, exceeding the Zacks Consensus Estimate by 5.12%, and showing significant growth from $165.97 million in the same quarter last year [2] - Over the last four quarters, Tempus has surpassed consensus EPS estimates three times and topped consensus revenue estimates three times as well [2] Stock Performance - Tempus shares have increased approximately 74% since the beginning of the year, significantly outperforming the S&P 500's gain of 7.8% [3] - The current consensus EPS estimate for the upcoming quarter is -$0.18 on revenues of $325.52 million, and for the current fiscal year, it is -$0.67 on revenues of $1.24 billion [7] Industry Outlook - The Medical Info Systems industry, to which Tempus belongs, is currently ranked in the top 37% of over 250 Zacks industries, indicating a favorable outlook compared to the bottom 50% [8] - The performance of Tempus's stock may be influenced by the overall industry outlook, as empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions [5][8]